About us

We are SANOBIOTEC

A team dedicated to the development, production, marketing and validation of minor cannabinoids.
ABOUT US

At Sanobiotec, we are committed to cannabinoid research and development for a broad range of applications in the pharmaceutical and wellness industries. Our portfolio includes both mainstream and rare cannabinoids, including the sought-after CBN, CBC and CBDV, and a significant IP collection which also covers patentable processes. The combination of synthesis, biosynthesis and extraction capabilities enables the development of optimal production methods for each compound, leading to superior quality and efficiency.

OUR WORK

We are fascinated with cannabinoids, their untapped potential and possibilities. Minor cannabinoids are particularly appealing in this regard and they are finally gaining the well-deserved attention. Research of these compounds is rapidly accelerating, and so does the interest in clinical applications of cannabinoid pharmaceuticals. Our partnerships with leading scientific organisations help us to concentrate deeper on this group of products and expand our R&D capabilities.

OUR VALUES

Our people are living and breathing cannabinoid innovation and share a mission to reveal the true health power of cannabinoids. Our values help us define our purpose as ENABLERS: Excellence oriented, Nature driven, Ambitious, Balanced, Learning, Empowering, Responsible and Sustainable.

OUR COMPANIES

Sanobiotec is a group of four companies, all having their unique approach towards cannabinoids.

Sanobiotec Hub sets our strategic business directions, maintains and establishes partnerships and nurtures the people behind the brands.

More

Sanobiotec R&D develops new products and testing methods, transfers products to further production stages, provides know-how and support.

More

Sanobiotec Bio conducts product validation research and explores the processes of complex biosynthetic pathways.

More

Sanobiotec Novus takes care of the manufacturing, sales and customer services.

More

OUR NEWS